Premium clinical research commercial drug supply by ClientPharma: Project Management – ClientPharma’s clinical trial Project Management team brings proficiency in management and mitigation of risks. You can say goodbye to issues and delays and hello to peace-of-mind. Warehousing and Distribution – ClientPharma handles the numerous challenges of obtaining medicines quickly, in multiple lots, with ranging expiry dating—and we can do this, procuring from any region in the world. To learn more about how we can improve your clinical trial supply experience or receive a quote, please feel free to get in touch. Find more details at accurate pharmaceutical supply.
ClientPharma is licensed and follows regulatory directives and guidelines, complying with Good Distribution Practice (GDP) for Medicines for Human Use, 2013/C 343/01. Our Quality Department is responsible for vigorously maintaining the quality and integrity of your products through our comprehensive Quality Management System. Continuous focus and commitment to quality assures compliance across the board — for the client, for the regulatory agencies, and most importantly, for the patient.
From sample requests to global bulk supply procurement and distribution, we work as an extension of your team to guide you through the appropriate steps to mitigate risks. From start-to-finish, we utilize our extensive expertise and breadth of knowledge to navigate: Market Intelligence; Supply Chain Planning; Risk Management; Sourcing; Waste Management; Storage & Distribution; Documentation Management; Returns, Reconciliation & Destruction Services.
ClientPharma is proud to be the new sponsor of the Stretton Starlings netball team, continuing our goal to support equality in sports. As a result, we wish to showcase the team’s smart new match uniforms for the upcoming season, which sets a new precedent as an innovative way forward with the team wearing t-shirts rather than the ‘status quo’ netball dresses. After forming the team six months ago, the Starlings have just completed their first season collectively in a competitive netball league for the first time, emphasizing that age is no barrier with a range from 14 to 47 years old. The team has high expectations for the upcoming season and wishes to inspire, grow, develop, and celebrate local talent in welcoming ladies of all ages and abilities to come and join the team! Stretton Starlings are eager, driven and determined to commence the second season of the Leagues4you Burton-Upon-Trent Netball League, starting from the 9th of January 2023. See additional information on https://www.clientpharma.com/.
ClientPharma (CP), a global clinical trial supply company, specializing in the procurement of commercial drug for clinical research, announced today it has formed a strategic partnership with TrialCard, a full-service life sciences commercialization partner. As a result, global clinical supply and operations teams can now single source their commercial drug requirements by utilizing two best-in-class solution providers. TrialCard Incorporated is a full-service life sciences commercialization partner that provides comprehensive solutions that span the entire biopharmaceutical value chain. In addition to a foundation of fully integrated, digitally enabled patient support services, its broader offerings include everything from late-stage clinical trial management to post-marketing HCP engagement services and proprietary data-as-a-service payer intelligence and insights. Founded in 2000, TrialCard provides commercialization needs for more than 160 life science customers and has connected over 35 million patients with more than $18 billion in branded drug savings to date. The company is headquartered in Morrisville, North Carolina.
Forecasts by their very definition involve a degree of uncertainty. When a company fails to meet demand it can have major implications on the drug and the pharmaceutical company. The company may experience loss in sales, a bad reputation for unreliability with customers and overworked employees. It has been reported that where the drug itself is concerned, if the launch of a medicine is delayed due to a failure in estimation, it costs on average $15 million per drug, per day. Further research has also shown that a blockbuster drug will lose $1 billion in revenue annually until capacity is developed to meet demand. Overestimations in demand generally happen when the market is at its most volatile, or, if the reach of a new drug has been over estimated. These inaccuracies can cost companies. If a product’s demand is overestimated, companies have to find ways to correct their misjudgement by cutting the price of medicines which reduces margins and by making employees redundant to pay for the excess of stock. In some cases companies also have to destroy stock that has not been sold.